You reviewed .... for this content
out of 5
5...
4...
3...
2...
1...
Select Select events(s)
Select Year(s)
Select Resource type(s)
Select Topic(s)
10 year experience of Takotsubo Syndrome
Event : HFA Discoveries 2020
18F-FDG PET/CT brain glucose metabolism as a marker of different types of depression comorbidity in chronic systolic heart failure patients
Event : ESC Congress 2020
24hour urinary sodium excretion in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
3-year follow-up results of heart failure patients included in the Journey HF-TR study
36,269 patients with chronic cardiovascular, metabolic and renal conditions: impact on clinical outcomes, medical resource use and health-related costs of deranged serum potassium levels
6-hours levosimendan outpatient administration in advanced heart failure: Our 93 sessions experience
92 aetiologic factors for heart failure: Prevalence, co-occurrence, prognosis and potential for prevention in 170 885 incident HF cases
A cardiac rehabilitation program increases the acute respond of endothelial progenitor cells after maximum exercise in patients with chronic heart failure
A comparison of in-hospital initiation of sacubitril/valsartan vs ACE inhibitor in patients with acute decompensated heart failure following ST elevation myocardial infarction
A comparison of machine learning models for predicting rehospitalisation and death after a first hospitalisation with heart failure
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease